DULOXETINE ALEMBIC duloxetine (as hydrochloride) 30 mg enteric capsule blister pack

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

duloxetine hydrochloride, Quantity: 33.65 mg

Dostępny od:

Alembic Pharmaceuticals Australia Pty Ltd

INN (International Nazwa):

Duloxetine hydrochloride

Forma farmaceutyczna:

Capsule, enteric

Skład:

Excipient Ingredients: indigo carmine; triethyl citrate; Gelatin; hypromellose phthalate; purified talc; sucrose; hypromellose; titanium dioxide; maize starch; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; iron oxide yellow; Shellac; strong ammonia solution

Droga podania:

Oral

Sztuk w opakowaniu:

28 capsules

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Duloxetine capsules are indicated for the treatment of major depressive disorder (MDD).,Treatment of Diabetic Peripheral Neuropathic Pain (DPNP). Treatment of Generalised Anxiety Disorder (GAD). Duloxetine capsules are indicated for the treatment of major depressive disorder (MDD).,Treatment of Diabetic Peripheral Neuropathic Pain (DPNP). Treatment of Generalised Anxiety Disorder (GAD).

Podsumowanie produktu:

Visual Identification: Opaque blue/white hard gelatin capsule '157' on body and 'A' on cap with green ink; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius

Status autoryzacji:

Licence status A

Data autoryzacji:

2013-06-14